Psoriasis Drugs Market Size, Trends, Analysis, and Outlook By Therapeutic Class (Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Vitamin-D Analogues, Others), By Treatment (Topicals, Systemic, Biologics), by Region, Country, Segment, and Companies, 2024-2030
The global Psoriasis Drugs market size is poised to register 8.46% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Psoriasis Drugs market across By Therapeutic Class (Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Vitamin-D Analogues, Others), By Treatment (Topicals, Systemic, Biologics).
The Psoriasis Drugs Market is experiencing growth propelled by increasing prevalence of psoriasis, expanding treatment options and pipeline developments, and growing awareness of the disease burden. Psoriasis drugs encompass a variety of topical, systemic, and biologic therapies aimed at reducing inflammation, controlling symptoms, and improving quality of life for patients with psoriasis and psoriatic arthritis. Key trends shaping its future include the development of novel biologic agents targeting specific inflammatory pathways and cytokines involved in psoriasis pathogenesis, integration of small molecule inhibitors and gene therapies for personalized treatment approaches, and customization of treatment regimens based on disease severity, patient preferences, and comorbidities. Additionally, increasing adoption of combination therapy and step-wise treatment algorithms, expansion of biologic drug access and affordability programs, and regulatory approvals for new psoriasis treatments contribute to market expansion.
Psoriasis Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Psoriasis Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Psoriasis Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Psoriasis Drugs industry.
Key market trends defining the global Psoriasis Drugs demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Psoriasis Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Psoriasis Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Psoriasis Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Psoriasis Drugs industry
Leading Psoriasis Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Psoriasis Drugs companies.
Psoriasis Drugs Market Study- Strategic Analysis Review
The Psoriasis Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Psoriasis Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Psoriasis Drugs Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Psoriasis Drugs Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Psoriasis Drugs market segments. Similarly, Strong end-user demand is encouraging Canadian Psoriasis Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Psoriasis Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Psoriasis Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Psoriasis Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Psoriasis Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Psoriasis Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Psoriasis Drugs in Asia Pacific. In particular, China, India, and South East Asian Psoriasis Drugs markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Psoriasis Drugs Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Psoriasis Drugs Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Psoriasis Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Psoriasis Drugs.
Psoriasis Drugs Market Company Profiles
The global Psoriasis Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Amgen Inc, AstraZenca, Biogen Idec, Boehringer Ingelheim, Celgene Corp, Dr.Reddy`s Laboratories, Eli Lilly and Company, Forward Pharma, Janssen Biotech Inc, Leo Pharma AS, Merck and Co. Inc, Novartis AG, Pfizer Inc, Stiefel Laboratories Inc, Sunpharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, UCB SA, Valeant Pharmaceuticals
Recent Psoriasis Drugs Market Developments
The global Psoriasis Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Psoriasis Drugs Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Therapeutic Class
Tumor Necrosis Factor Inhibitors
Interleukin Inhibitors
Vitamin-D Analogues
Others
By Treatment
Topicals
Systemic
Biologics
Geographical Segmentation:
AbbVie Inc
Amgen Inc
AstraZenca
Biogen Idec
Boehringer Ingelheim
Celgene Corp
Dr.Reddy`s Laboratories
Eli Lilly and Company
Forward Pharma
Janssen Biotech Inc
Leo Pharma AS
Merck and Co. Inc
Novartis AG
Pfizer Inc
Stiefel Laboratories Inc
Sunpharmaceutical Industries Ltd
Takeda Pharmaceutical Company Ltd
UCB SA
Valeant Pharmaceuticals
Formats Available: Excel, PDF, and PPT
The Psoriasis Drugs Market is experiencing growth propelled by increasing prevalence of psoriasis, expanding treatment options and pipeline developments, and growing awareness of the disease burden. Psoriasis drugs encompass a variety of topical, systemic, and biologic therapies aimed at reducing inflammation, controlling symptoms, and improving quality of life for patients with psoriasis and psoriatic arthritis. Key trends shaping its future include the development of novel biologic agents targeting specific inflammatory pathways and cytokines involved in psoriasis pathogenesis, integration of small molecule inhibitors and gene therapies for personalized treatment approaches, and customization of treatment regimens based on disease severity, patient preferences, and comorbidities. Additionally, increasing adoption of combination therapy and step-wise treatment algorithms, expansion of biologic drug access and affordability programs, and regulatory approvals for new psoriasis treatments contribute to market expansion.
Psoriasis Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Psoriasis Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Psoriasis Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Psoriasis Drugs industry.
Key market trends defining the global Psoriasis Drugs demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Psoriasis Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Psoriasis Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Psoriasis Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Psoriasis Drugs industry
Leading Psoriasis Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Psoriasis Drugs companies.
Psoriasis Drugs Market Study- Strategic Analysis Review
The Psoriasis Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Psoriasis Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Psoriasis Drugs Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Psoriasis Drugs Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Psoriasis Drugs market segments. Similarly, Strong end-user demand is encouraging Canadian Psoriasis Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Psoriasis Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Psoriasis Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Psoriasis Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Psoriasis Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Psoriasis Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Psoriasis Drugs in Asia Pacific. In particular, China, India, and South East Asian Psoriasis Drugs markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Psoriasis Drugs Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Psoriasis Drugs Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Psoriasis Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Psoriasis Drugs.
Psoriasis Drugs Market Company Profiles
The global Psoriasis Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Amgen Inc, AstraZenca, Biogen Idec, Boehringer Ingelheim, Celgene Corp, Dr.Reddy`s Laboratories, Eli Lilly and Company, Forward Pharma, Janssen Biotech Inc, Leo Pharma AS, Merck and Co. Inc, Novartis AG, Pfizer Inc, Stiefel Laboratories Inc, Sunpharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, UCB SA, Valeant Pharmaceuticals
Recent Psoriasis Drugs Market Developments
The global Psoriasis Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Psoriasis Drugs Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Therapeutic Class
Tumor Necrosis Factor Inhibitors
Interleukin Inhibitors
Vitamin-D Analogues
Others
By Treatment
Topicals
Systemic
Biologics
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Amgen Inc
AstraZenca
Biogen Idec
Boehringer Ingelheim
Celgene Corp
Dr.Reddy`s Laboratories
Eli Lilly and Company
Forward Pharma
Janssen Biotech Inc
Leo Pharma AS
Merck and Co. Inc
Novartis AG
Pfizer Inc
Stiefel Laboratories Inc
Sunpharmaceutical Industries Ltd
Takeda Pharmaceutical Company Ltd
UCB SA
Valeant Pharmaceuticals
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Psoriasis Drugs Market Overview and Key Findings, 2024
1.2 Psoriasis Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Psoriasis Drugs Market Growth Opportunities to 2030
1.4 Key Psoriasis Drugs Market Trends and Challenges
1.4.1 Psoriasis Drugs Market Drivers and Trends
1.4.2 Psoriasis Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Psoriasis Drugs Companies
2. PSORIASIS DRUGS MARKET SIZE OUTLOOK TO 2030
2.1 Psoriasis Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Psoriasis Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PSORIASIS DRUGS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PSORIASIS DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Therapeutic Class
Tumor Necrosis Factor Inhibitors
Interleukin Inhibitors
Vitamin-D Analogues
Others
By Treatment
Topicals
Systemic
Biologics
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Psoriasis Drugs Market, 2025
5.2 Asia Pacific Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Psoriasis Drugs Market, 2025
5.5 Europe Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Psoriasis Drugs Market, 2025
5.8 North America Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Psoriasis Drugs Market, 2025
5.11 South America Pacific Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Psoriasis Drugs Market, 2025
5.14 Middle East Africa Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Psoriasis Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Psoriasis Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Psoriasis Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Psoriasis Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Psoriasis Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Psoriasis Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Psoriasis Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Psoriasis Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Psoriasis Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Psoriasis Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Psoriasis Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Psoriasis Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Psoriasis Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Psoriasis Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Psoriasis Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Psoriasis Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Psoriasis Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Psoriasis Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Psoriasis Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Psoriasis Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Psoriasis Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Psoriasis Drugs Industry Drivers and Opportunities
7. PSORIASIS DRUGS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PSORIASIS DRUGS COMPANY PROFILES
8.1 Profiles of Leading Psoriasis Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Amgen Inc
AstraZenca
Biogen Idec
Boehringer Ingelheim
Celgene Corp
Dr.Reddy`s Laboratories
Eli Lilly and Company
Forward Pharma
Janssen Biotech Inc
Leo Pharma AS
Merck and Co. Inc
Novartis AG
Pfizer Inc
Stiefel Laboratories Inc
Sunpharmaceutical Industries Ltd
Takeda Pharmaceutical Company Ltd
UCB SA
Valeant Pharmaceuticals
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Psoriasis Drugs Market Overview and Key Findings, 2024
1.2 Psoriasis Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Psoriasis Drugs Market Growth Opportunities to 2030
1.4 Key Psoriasis Drugs Market Trends and Challenges
1.4.1 Psoriasis Drugs Market Drivers and Trends
1.4.2 Psoriasis Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Psoriasis Drugs Companies
2. PSORIASIS DRUGS MARKET SIZE OUTLOOK TO 2030
2.1 Psoriasis Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Psoriasis Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PSORIASIS DRUGS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PSORIASIS DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Therapeutic Class
Tumor Necrosis Factor Inhibitors
Interleukin Inhibitors
Vitamin-D Analogues
Others
By Treatment
Topicals
Systemic
Biologics
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Psoriasis Drugs Market, 2025
5.2 Asia Pacific Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Psoriasis Drugs Market, 2025
5.5 Europe Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Psoriasis Drugs Market, 2025
5.8 North America Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Psoriasis Drugs Market, 2025
5.11 South America Pacific Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Psoriasis Drugs Market, 2025
5.14 Middle East Africa Psoriasis Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Psoriasis Drugs Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Psoriasis Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Psoriasis Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Psoriasis Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Psoriasis Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Psoriasis Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Psoriasis Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Psoriasis Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Psoriasis Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Psoriasis Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Psoriasis Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Psoriasis Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Psoriasis Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Psoriasis Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Psoriasis Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Psoriasis Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Psoriasis Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Psoriasis Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Psoriasis Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Psoriasis Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Psoriasis Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Psoriasis Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Psoriasis Drugs Industry Drivers and Opportunities
7. PSORIASIS DRUGS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PSORIASIS DRUGS COMPANY PROFILES
8.1 Profiles of Leading Psoriasis Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Amgen Inc
AstraZenca
Biogen Idec
Boehringer Ingelheim
Celgene Corp
Dr.Reddy`s Laboratories
Eli Lilly and Company
Forward Pharma
Janssen Biotech Inc
Leo Pharma AS
Merck and Co. Inc
Novartis AG
Pfizer Inc
Stiefel Laboratories Inc
Sunpharmaceutical Industries Ltd
Takeda Pharmaceutical Company Ltd
UCB SA
Valeant Pharmaceuticals
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
